Cell cycle phase distribution in tumor cells

Cell cycle phase distribution in tumor cells" refers to the measurement and analysis of the proportion of cancer cells present in different phases of the cell cycle—typically G1, S, G2, and M phases. This parameter is widely used as an experimental readout to assess how tumors grow and respond to therapies that affect cell division. The cell cycle itself is regulated by cyclins, cyclin-dependent kinases (CDKs), checkpoint kinases, and other proteins[1][2][3][6]. In cancer research and clinical studies, analyzing the distribution of tumor cells across these phases helps evaluate proliferative activity or detect effects from drugs targeting specific points in the cell division process[2][3]. However, "cell cycle phase distribution" describes an analytical method or biological state rather than any single protein, receptor, enzyme, or canonical therapeutic target. This entry does not correspond to an individual molecular entity but rather describes an aggregate property measured across populations of tumor cells. Therefore it should not be considered a canonical drug target such as a receptor or enzyme[2][3].

Other names

Cell cycle phase distribution in tumor cellsTumor cell cycle phasesCell cycle analysis in cancer cells